Alfredo Ramı́rez

ORCID: 0000-0003-4991-763X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Genetic Associations and Epidemiology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Functional Brain Connectivity Studies
  • Bioinformatics and Genomic Networks
  • Parkinson's Disease Mechanisms and Treatments
  • Health, Environment, Cognitive Aging
  • Genetics and Neurodevelopmental Disorders
  • Tryptophan and brain disorders
  • Epigenetics and DNA Methylation
  • Genomics and Rare Diseases
  • Nutritional Studies and Diet
  • Neurological Disease Mechanisms and Treatments
  • Diet and metabolism studies
  • Autism Spectrum Disorder Research
  • Nutrition, Genetics, and Disease
  • Advanced Neuroimaging Techniques and Applications
  • RNA regulation and disease
  • Obsessive-Compulsive Spectrum Disorders
  • Folate and B Vitamins Research
  • Neurological diseases and metabolism
  • Metabolomics and Mass Spectrometry Studies
  • Amyotrophic Lateral Sclerosis Research
  • Nuclear Receptors and Signaling

Hospital Universitario Son Espases
2020-2025

German Center for Neurodegenerative Diseases
2014-2025

University Hospital Cologne
2005-2025

Institute for Neurodegenerative Disorders
2018-2025

University of Cologne
2016-2025

University Hospital Bonn
2015-2025

Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
2020-2025

The University of Texas Health Science Center at San Antonio
2018-2025

Fundacion Centro De Investigacion De Enfermedades Neurologicas
2025

Universitätsmedizin Göttingen
2025

The identification of subjects at high risk for Alzheimer's disease is important prognosis and early intervention. We investigated the polygenic architecture accuracy prediction models, including excluding component in model. This study used genotype data from powerful dataset comprising 17 008 cases 37 154 controls obtained International Genomics Project (IGAP). Polygenic score analysis tested whether alleles identified to associate with one sample set were significantly enriched relative...

10.1093/brain/awv268 article EN Brain 2015-10-21

Retrograde axonal transport of nerve growth factor (NGF) signals is critical for the survival, differentiation, and maintenance peripheral sympathetic sensory neurons basal forebrain cholinergic neurons. However, mechanisms by which NGF signal propagated from axon terminal to cell body are yet be fully elucidated. To gain insight into mechanisms, we used quantum dot-labeled (QD-NGF) track movement in real time compartmentalized culture rat dorsal root ganglion (DRG) Our studies showed that...

10.1073/pnas.0706192104 article EN Proceedings of the National Academy of Sciences 2007-08-15

Parkinson disease (PD) is a progressive neurodegenerative disorder pathologically characterized by the loss of dopaminergic neurons from substantia nigra pars compacta and presence, in affected brain regions, protein inclusions named Lewy bodies (LBs). The ATP13A2 gene (locus PARK9) encodes ATP13A2, lysosomal type 5 P-type ATPase that linked to autosomal recessive familial parkinsonism. physiological function hence its role PD, remains be elucidated. Here, we show PD-linked mutations lead...

10.1073/pnas.1112368109 article EN Proceedings of the National Academy of Sciences 2012-05-30
Gyungah Jun Carla A. Ibrahim‐Verbaas Maria Vronskaya Jean‐Charles Lambert Jaeyoon Chung and 95 more Adam C. Naj Brian W. Kunkle Li‐Shun Wang Joshua C. Bis Céline Bellenguez Denise Harold Kathryn L. Lunetta Anita L. DeStefano Benjamin Grenier‐Boley Rebecca Sims Gary W. Beecham Albert V. Smith Vincent Chouraki Kara L. Hamilton‐Nelson M. Arfan Ikram Nathalie Fiévet Nicola Denning Eden R. Martin Helena Schmidt Yoichiro Kamatani Melanie Dunstan Otto Valladares Agustín Ruiz Laza Diana Zélénika Alfredo Ramı́rez Tatiana Foroud Sung‐Hyuk Choi Anne Boland Tim Becker Walter A. Kukull Sven J. van der Lee Florence Pasquier Carlos Cruchaga Duane Beekly Annette L. Fitzpatrick Olivier Hanon Michael Gill Robert C. Barber Vilmundur Guðnason Dominique Campion Seth Love David A. Bennett Najaf Amin Claudine Berr Magda Tsolaki Joseph D. Buxbaum Oscar L. López Vincent Deramecourt Nick C. Fox Laura B. Cantwell Lluís Tárraga Carole Dufouil John Hardy Paul K. Crane Gudny Eiriksdottir Didier Hannequin Robert Clarke Denis A. Evans Thomas H. Mosley Luc Letenneur Carol Brayne Wolfgang Maier Philip L. De Jager Valur Emilsson Dartigues Jf Harald Hampel M. Ilyas Kamboh Renée F.A.G. de Bruijn Christophe Tzourio Pau Pástor Eric B. Larson Jerome I. Rotter Michael O’Donovan Thomas J. Montine Michael A. Nalls Simon Mead Eric M. Reiman Pálmi V. Jónsson Clive Holmes Peter St George‐Hyslop Merçé Boada Peter Passmore Jens R. Wendland R. Schmidt Kevin Morgan Ashley R. Winslow John Powell M Carasquillo Steven G. Younkin Jóhanna Jakobsdóttir John Kauwe Kirk C. Wilhelmsen Dan Rujescu Markus M. Nöthen Albert Hofman

10.1038/mp.2015.23 article EN Molecular Psychiatry 2015-03-17

Deep phenotyping and longitudinal assessment of predementia at-risk states Alzheimer's disease (AD) are required to define populations outcomes for dementia prevention trials. Subjective cognitive decline (SCD) is a pre-mild impairment (pre-MCI) state dementia, which emerges as highly promising target AD prevention.The German Center Neurodegenerative Diseases (DZNE) conducting the multicenter DZNE-Longitudinal Cognitive Impairment Dementia Study (DELCODE), focuses on characterization SCD in...

10.1186/s13195-017-0314-2 article EN cc-by Alzheimer s Research & Therapy 2018-02-07

Abstract Introduction Identifying circulating metabolites that are associated with cognition and dementia may improve our understanding of the pathogenesis provide crucial readouts for preventive therapeutic interventions. Methods We studied 299 in relation to (general cognitive ability) two discovery cohorts (N total = 5658). Metabolites significantly after adjusting multiple testing were replicated four independent 6652), associations Alzheimer's disease 25,872) lifestyle factors 5168)...

10.1016/j.jalz.2017.11.012 article EN cc-by-nc-nd Alzheimer s & Dementia 2018-01-06
Henne Holstege Marc Hulsman Camille Charbonnier Benjamin Grenier‐Boley Olivier Quenez and 95 more Detelina Grozeva Jeroen van Rooij Rebecca Sims Shahzad Ahmad Najaf Amin Penny J. Norsworthy Oriol Dols‐Icardo Holger Hummerich Amit Kawalia Philippe Amouyel Gary W. Beecham Claudine Berr Joshua C. Bis Anne Boland Paola Bossù Femke H. Bouwman José Brás Dominique Campion J. Nicholas Cochran Antonio Daniele Jean‐François Dartigues Stéphanie Debette Jean-François Deleuze Nicola Denning Anita L. DeStefano Lindsay A. Farrer María Victoria Fernández Nick C. Fox Daniela Galimberti Emmanuelle Génin Gilles Thomas Yann Le Guen Rita Guerreiro Jonathan L. Haines Clive Holmes M. Arfan Ikram M. Kamran Ikram Iris E. Jansen Robert Kraaij M Lathrop Afina W. Lemstra Alberto Lleó Lauren Luckcuck Marcel M.A.M. Mannens Iain Marshall Eden R. Martin Carlo Masullo Richard Mayeux Patrizia Mecocci Alun Meggy Merel O. Mol Kevin Morgan R Myers Benedetta Nacmias Adam C. Naj Valerio Napolioni Florence Pasquier Pau Pástor Margaret A. Pericak‐Vance Rachel Raybould Richard Redon Marcel J. T. Reinders Anne‐Claire Richard Steffi G. Riedel‐Heller Fernando Rivadeneira Stéphane Rousseau Natalie S. Ryan Salha Saad Pascual Sánchez‐Juan Gerard D. Schellenberg Philip Scheltens Jonathan M. Schott Davide Seripa Sudha Seshadri Daoud Sie Erik A. Sistermans Sandro Sorbi Resie van Spaendonk Gianfranco Spalletta Niccoló Tesi Betty M. Tijms André G. Uitterlinden Sven J. van der Lee Pieter Jelle Visser Michael Wagner David Wallon Li-San Wang Aline Zaréa Jordi Clarimón John C. van Swieten Michael D. Greicius Jennifer S. Yokoyama Carlos Cruchaga John Hardy Alfredo Ramı́rez

Abstract Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability approximately 70% 1 . The genetic component AD been mainly assessed using genome-wide association studies, which do not capture risk contributed by rare variants 2 Here, we compared gene-based burden damaging in exome sequencing data from 32,558 individuals—16,036 cases and 16,522 controls. Next to TREM2 , SORL1 ABCA7 observed a significant rare, predicted ATP8B4 ABCA1 with risk, suggestive signal...

10.1038/s41588-022-01208-7 article EN cc-by Nature Genetics 2022-11-21

To determine whether following a Mediterranean-like diet (MeDi) relates to cognitive functions and in vivo biomarkers for Alzheimer disease (AD), we analyzed cross-sectional data from the German DZNE-Longitudinal Cognitive Impairment Dementia Study. METHOD: The sample (n=512, mean age: 69.5±5.9 years) included 169 cognitively normal participants subjects at higher AD risk (53 with relatives AD, 209 subjective decline, 81 mild impairment). We defined MeDi adherence based on Food Frequency...

10.1212/wnl.0000000000012067 article EN Neurology 2021-05-07

Abstract Introduction It is uncertain whether subjective cognitive decline (SCD) in individuals who seek medical help serves the identification of initial symptomatic stage 2 Alzheimer's disease (AD) continuum. Methods Cross‐sectional and longitudinal data from multicenter, memory clinic–based DELCODE study. Results The SCD group showed slightly worse cognition as well more subtle functional behavioral symptoms than control (CO). SCD–A+ cases (39.3% all SCD) greater hippocampal atrophy,...

10.1002/alz.12674 article EN cc-by-nc-nd Alzheimer s & Dementia 2022-04-22

Minimally invasive biomarkers are urgently needed to detect molecular pathology in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Here, we show that plasma extracellular vesicles (EVs) contain quantifiable amounts of TDP-43 full-length tau, which allow the quantification 3-repeat (3R) 4-repeat (4R) tau isoforms. Plasma EV levels 3R/4R ratios were determined a cohort 704 patients, including 37 genetically 31 neuropathologically proven cases. Diagnostic groups comprised...

10.1038/s41591-024-02937-4 article EN cc-by Nature Medicine 2024-06-01
Jiao Luo Jesper Qvist Thomassen Céline Bellenguez Benjamin Grenier‐Boley Itziar de Rojas and 91 more Atahualpa Castillo-Morales Kayenat Parveen Fahri Küçükali Aude Nicolas Oliver Peters Anja Schneider Martin Dichgans Dan Rujescu Norbert Scherbaum Jürgen Deckert Steffi G. Riedel‐Heller Lucrezia Hausner Laura Molina‐Porcel Emrah Düzel Timo Grimmer Jens Wiltfang Stefanie Heilmann‐Heimbach Susanne Moebus Thomas Tegos Nikolaos Scarmeas Jordi Clarimón Fermín Moreno Jordi Pérez‐Tur María J. Bullido Pau Pástor Raquel Sánchez‐Valle Victoria Álvarez Merçé Boada Pablo García‐González Raquel Puerta Pablo Mir Luís Miguel Real Gerard Piñol‐Ripoll José María García‐Alberca José Luís Royo Eloy Rodríguez‐Rodríguez Hilkka Soininen Teemu Kuulasmaa Alexandre de Mendonça Shima Mehrabian Jakub Hort Martin Vyhnálek Sven J. van der Lee Caroline Graff Goran Papenberg Vilmantas Giedraitis Anne Boland Delphine Bacq‐Daian Jean‐François Deleuze Gaël Nicolas Carole Dufouil Florence Pasquier Olivier Hanon Stéphanie Debette Edna Grünblatt Julius Popp Luisa Benussi Daniela Galimberti Beatrice Arosio Patrizia Mecocci Vincenzo Solfrizzi Lucilla Parnetti Alessio Squassina Lucio Tremolizzo Barbara Borroni Benedetta Nacmias Sandro Sorbi Paolo Caffarra Davide Seripa Innocenzo Rainero Antonio Daniele Carlo Masullo Gianfranco Spalletta Julie Williams Philippe Amouyel Frank Jessen Patrick G. Kehoe Magda Tsolaki Giacomina Rossi Pascual Sánchez‐Juan Kristel Sleegers Martin Ingelsson Ole A. Andreassen Mikko Hiltunen Cornelia M. van Duijn Rebecca Sims Wiesje M. van der Flier Agustı́n Ruiz Alfredo Ramı́rez Jean‐Charles Lambert Ruth Frikke‐Schmidt

Importance An estimated 40% of dementia is potentially preventable by modifying 12 risk factors throughout the life course. However, robust evidence for most these lacking. Effective interventions should target in causal pathway to dementia. Objective To comprehensively disentangle aspects modifiable Alzheimer disease (AD) inspire new drug targeting and improved prevention. Design, Setting, Participants This genetic association study was conducted using 2-sample univariable multivariable...

10.1001/jamanetworkopen.2023.13734 article EN cc-by-nc-nd JAMA Network Open 2023-05-17

Background Mutations in Parkin are the most common cause of autosomal recessive Parkinson disease (PD). The mitochondrially localized E3 ubiquitin-protein ligase has been reported to be involved respiratory chain function and mitochondrial dynamics. More recent publications also described a link between mitophagy. Methodology/Principal Findings In this study, we investigated impact mutations on morphology human cellular model. Fibroblasts were obtained from three members an Italian PD family...

10.1371/journal.pone.0012962 article EN cc-by PLoS ONE 2010-09-27
Coming Soon ...